IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 124 filers reported holding IMMUNOVANT INC in Q3 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31,784,309 | +152.1% | 827,932 | +24.6% | 0.02% | +166.7% |
Q2 2023 | $12,608,335 | +74967.5% | 664,646 | -38.6% | 0.01% | -40.0% |
Q1 2023 | $16,796 | +1048.1% | 1,082,902 | +1213.5% | 0.01% | +900.0% |
Q4 2022 | $1,463 | -99.9% | 82,441 | -76.1% | 0.00% | 0.0% |
Q3 2022 | $1,927,000 | +48.1% | 345,257 | +3.5% | 0.00% | 0.0% |
Q2 2022 | $1,301,000 | -60.4% | 333,553 | -44.1% | 0.00% | -50.0% |
Q1 2022 | $3,286,000 | +14.1% | 596,280 | +76.4% | 0.00% | +100.0% |
Q4 2021 | $2,879,000 | -28.0% | 337,968 | -26.5% | 0.00% | -50.0% |
Q3 2021 | $3,999,000 | -58.1% | 460,126 | -49.0% | 0.00% | -66.7% |
Q2 2021 | $9,542,000 | +38.4% | 902,723 | +110.0% | 0.01% | +20.0% |
Q1 2021 | $6,897,000 | -64.5% | 429,962 | +2.1% | 0.01% | -64.3% |
Q4 2020 | $19,454,000 | -3.6% | 421,184 | -26.6% | 0.01% | -44.0% |
Q3 2020 | $20,180,000 | +81.3% | 573,463 | +25.4% | 0.02% | +66.7% |
Q2 2020 | $11,131,000 | +56.5% | 457,134 | +0.0% | 0.02% | -6.2% |
Q1 2020 | $7,114,000 | – | 457,076 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alpine Global Management, LLC | 3,007,000 | $25,620,000 | 3.77% |
Deep Track Capital, LP | 4,775,000 | $40,683,000 | 2.87% |
Octagon Capital Advisors LP | 572,862 | $4,881,000 | 0.95% |
Eventide Asset Management | 4,950,000 | $42,174,000 | 0.54% |
WITTENBERG INVESTMENT MANAGEMENT, INC. | 140,500 | $1,197,000 | 0.44% |
FRAZIER MANAGEMENT LLC | 585,759 | $4,991,000 | 0.38% |
MANGROVE PARTNERS IM, LLC | 688,000 | $5,862,000 | 0.35% |
BCK CAPITAL MANAGEMENT LP | 54,293 | $463,000 | 0.31% |
EcoR1 Capital, LLC | 1,140,819 | $9,720,000 | 0.31% |
MANGROVE PARTNERS IM, LLC | 570,400 | $4,860,000 | 0.29% |